MedTrace Logo

The Effects of Moviprep With Simethicone on Colonic Bubbles

NCT01209806 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2019-07-15

No results posted yet for this study

Summary

The purpose of this study is to determine whether the administration of PEG along with simethicone will reduce the incidence of colonic bubbles that interfere with polyp detection.

Conditions

  • Bubbles in Colon at Time of Colonoscopy

Interventions

DRUG

simethicone

400 mg simethicone at 6pm night prior to colonoscopy 400 mg simethicone 4 hours before colonoscopy

Sponsors & Collaborators

  • Thomas Jefferson University

    lead OTHER

Principal Investigators

  • David Kastenberg, MD · Thomas Jefferson University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2012-08-31
Completion
2012-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01209806 on ClinicalTrials.gov